Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31705
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKelly, Richard-
dc.contributor.authorJensen, Andrew-
dc.contributor.authorKarunaratna, Nathasha-
dc.contributor.authorWong, Shirley-
dc.contributor.authorShapiro, Julia-
dc.contributor.authorWeickhardt, Andrew J-
dc.contributor.authorParente, Phillip-
dc.contributor.authorAzad, Arun A-
dc.contributor.authorUccellini, Anthony-
dc.contributor.authorTorres, Javier-
dc.contributor.authorParnis, Francis-
dc.contributor.authorGoh, Jeffrey-
dc.contributor.authorKwan, Edmond M-
dc.contributor.authorBrown, Stephen-
dc.contributor.authorSteer, Christopher-
dc.contributor.authorWarren, Mark-
dc.contributor.authorGibbs, Peter-
dc.contributor.authorTran, Ben-
dc.contributor.authorAnton, Angelyn-
dc.date2022-
dc.date.accessioned2023-01-12T02:08:15Z-
dc.date.available2023-01-12T02:08:15Z-
dc.date.issued2023-
dc.identifier.citationBJU International 2023; 131(2)en_US
dc.identifier.issn1464-410X-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31705-
dc.language.isoeng-
dc.titleProstate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleBJU Internationalen_US
dc.identifier.affiliationWalter and Eliza Hall Institute of Medical Research, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationEpworth Health, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationEastern Health, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationWestern Health, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationAlfred Health, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen_US
dc.identifier.affiliationPeter MacCallum Cancer Centre, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationGoulburn Valley Health, Shepparton, Vic., Australia.en_US
dc.identifier.affiliationAdelaide Cancer Centre, Adelaide, SA, Australia.en_US
dc.identifier.affiliationRoyal Brisbane and Women's Hospital, Herston, Qld, Australia.en_US
dc.identifier.affiliationMonash Health, Melbourne, Vic., Australia.en_US
dc.identifier.affiliationBallarat Health, Ballarat, Vic., Australia.en_US
dc.identifier.affiliationBorder Medical Oncology, Albury, NSW, Australia.en_US
dc.identifier.affiliationBendigo Health, Bendigo, Vic., Australia.en_US
dc.identifier.doi10.1111/bju.15930en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-0622-5644en_US
dc.identifier.orcid0000-0001-7350-5622en_US
dc.identifier.orcid0000-0002-7053-680Xen_US
dc.identifier.pubmedid36371671-
local.name.researcherWeickhardt, Andrew J
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

42
checked on Oct 3, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.